JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC) Shares Down 0.1% – Here’s What Happened

JPMorgan Healthcare Leaders ETF (NASDAQ:JDOC)’s share price fell 0.1% during trading on Thursday . The stock traded as low as $55.85 and last traded at $55.85. 379 shares traded hands during mid-day trading, a decline of 60% from the average session volume of 954 shares. The stock had previously closed at $55.93.

JPMorgan Healthcare Leaders ETF Trading Up 0.7%

The firm has a fifty day simple moving average of $55.50 and a 200 day simple moving average of $57.14. The stock has a market cap of $11.33 million, a price-to-earnings ratio of 22.43 and a beta of 0.44.

Hedge Funds Weigh In On JPMorgan Healthcare Leaders ETF

Several large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC acquired a new position in JPMorgan Healthcare Leaders ETF in the 2nd quarter valued at approximately $1,166,000. Ignite Planners LLC raised its holdings in JPMorgan Healthcare Leaders ETF by 136.8% in the 4th quarter. Ignite Planners LLC now owns 9,460 shares of the company’s stock valued at $553,000 after acquiring an additional 5,465 shares in the last quarter. Sanctuary Advisors LLC raised its holdings in JPMorgan Healthcare Leaders ETF by 12.7% in the 4th quarter. Sanctuary Advisors LLC now owns 6,359 shares of the company’s stock valued at $368,000 after acquiring an additional 718 shares in the last quarter. Krilogy Financial LLC acquired a new position in JPMorgan Healthcare Leaders ETF in the 3rd quarter valued at approximately $325,000. Finally, Blue Water Asset Management acquired a new position in JPMorgan Healthcare Leaders ETF in the 4th quarter valued at approximately $237,000.

JPMorgan Healthcare Leaders ETF Company Profile

The JPMorgan Healthcare Leaders ETF Healthcare Leaders ETF (JDOC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in equity securities issued by pharmaceutical, biotechnology, healthcare services, healthcare technology, medical technology and life sciences companies located around the globe.The adviser seeks to provide long-term capital appreciation. JDOC was launched on Nov 1, 2023 and is issued by JPMorgan Chase.